Provided by Tiger Trade Technology Pte. Ltd.

BIOSTAR PHARM-B

3.500
+0.0752.19%
Volume:17.40K
Turnover:60.20K
Market Cap:1.37B
PE:-9.72
High:3.500
Open:3.430
Low:3.430
Close:3.425
52wk High:9.630
52wk Low:2.400
Shares:390.00M
HK Float Shares:390.00M
Volume Ratio:2.12
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.360
ROE:-18.04%
ROA:-10.34%
PB:1.76
PE(LYR):-9.72
PS:35.06

Loading ...

BIOSTAR PHARM-B boosts registered share capital to RMB 389.59 million via HKD 100.00 million H-share placement

Bulletin Express
·
Aug 05

Beijing Biostar Pharma Raises Registered Capital to RMB 389.59 Million After Allotting 25 Million New H Shares

Bulletin Express
·
Aug 04

Baheal Pharma Group Acquires 25 Million Shares of BIOSTAR PHARM-B at HK$4 Each

Stock News
·
Jul 21

Biostar Pharmaceuticals Holds Share Base Steady at 364.59 Million H Shares in June, Confirms Public Float Compliance

Bulletin Express
·
Jul 03

Beijing Biostar Pharmaceuticals Updates Board Structure and Committee Leadership

Bulletin Express
·
Jun 26

3 Global Penny Stocks With Market Caps Over US$80M To Watch

Simply Wall St.
·
Jun 26

Beijing Biostar Pharmaceuticals clarifies AGM agenda: connected-transaction vote and share-option items withdrawn, auditor fee capped at RMB1.48 million

Bulletin Express
·
Jun 12

BIOSTAR PHARM-B: May 2026 Filing Shows Stable Capital Base and Sufficient Public Float

Bulletin Express
·
Jun 02

Biostar Pharm-B Calls 26 Jun 2026 AGM: No 2025 Dividend, New Share Option Scheme, Board Refresh & Dual Mandates

Bulletin Express
·
May 28

Biostar Pharm-B: Four Utidelone Trials Secure ASCO 2026 Slots, Show Promising Efficacy in Breast, Ovarian and Prostate Cancers

Bulletin Express
·
May 27

BIOSTAR PHARM-B's UTD1 and UTD2 Clinical Data Selected for 2026 ASCO Annual Meeting

Stock News
·
May 27

Beijing Biostar Clarifies Share Option Scheme, Cuts Employee Sublimit to 1%

Bulletin Express
·
May 26

BIOSTAR PHARM-B clarifies HK$4.00 share subscription terms; proceeds earmarked for ADC R&D and Utidelone commercialization

Bulletin Express
·
May 21

BIOSTAR PHARM-B Proposes Adoption of Share Option Scheme

Stock News
·
May 07

Beijing Biostar Approves 10-Year Share Option Scheme, Seeks Shareholder Green Light for Full Board Mandate

Bulletin Express
·
May 07

Beijing Biostar Secures HK$100 million via Share Placement to Baheal Subsidiary

Bulletin Express
·
May 07

Beijing Biostar Pharmaceuticals Announces Plan for On-Market H-Share Buy-back of up to 10%

Bulletin Express
·
May 07

BIOSTAR PHARM-B Keeps Share Capital Unchanged at 364.59 Million H Shares in April 2026, Confirms Sufficient Public Float

Bulletin Express
·
May 06

Biostar Pharma Converts 147.87 Million Unlisted Shares, Expands H-Share Capital to 364.59 Million

Bulletin Express
·
May 06

BIOSTAR PHARM-B Proposes Appointment of Zhu Xiaodong as Independent Non-Executive Director

Stock News
·
Apr 28